nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—ABCB1—ovarian cancer	0.391	1	CbGaD
Fluphenazine—ABCB1—Topotecan—ovarian cancer	0.0334	0.267	CbGbCtD
Fluphenazine—ABCB1—Vinorelbine—ovarian cancer	0.0235	0.188	CbGbCtD
Fluphenazine—CYP2D6—Vinorelbine—ovarian cancer	0.0222	0.178	CbGbCtD
Fluphenazine—ABCB1—Paclitaxel—ovarian cancer	0.0165	0.132	CbGbCtD
Fluphenazine—ABCB1—Docetaxel—ovarian cancer	0.012	0.0957	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—ovarian cancer	0.00891	0.0714	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—ovarian cancer	0.0084	0.0672	CbGbCtD
Fluphenazine—CALM2—oviduct—ovarian cancer	0.00634	0.061	CbGeAlD
Fluphenazine—HTR2A—vein—ovarian cancer	0.00625	0.0601	CbGeAlD
Fluphenazine—Ileus paralytic—Vinorelbine—ovarian cancer	0.00407	0.022	CcSEcCtD
Fluphenazine—Pancytopenia—Altretamine—ovarian cancer	0.00388	0.021	CcSEcCtD
Fluphenazine—Pigmentation disorder—Paclitaxel—ovarian cancer	0.00355	0.0192	CcSEcCtD
Fluphenazine—Hypotensive—Paclitaxel—ovarian cancer	0.00325	0.0176	CcSEcCtD
Fluphenazine—Dermatitis atopic—Chlorambucil—ovarian cancer	0.00312	0.0169	CcSEcCtD
Fluphenazine—Blood creatine phosphokinase increased—Melphalan—ovarian cancer	0.00293	0.0158	CcSEcCtD
Fluphenazine—Ileus paralytic—Paclitaxel—ovarian cancer	0.00274	0.0148	CcSEcCtD
Fluphenazine—Dermatitis atopic—Melphalan—ovarian cancer	0.00272	0.0147	CcSEcCtD
Fluphenazine—CALM3—myometrium—ovarian cancer	0.00258	0.0249	CbGeAlD
Fluphenazine—Leukopenia—Altretamine—ovarian cancer	0.00255	0.0138	CcSEcCtD
Fluphenazine—Dyskinesia—Chlorambucil—ovarian cancer	0.00246	0.0133	CcSEcCtD
Fluphenazine—Faecaloma—Epirubicin—ovarian cancer	0.00237	0.0128	CcSEcCtD
Fluphenazine—Faecalith—Epirubicin—ovarian cancer	0.00237	0.0128	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—ovarian cancer	0.00219	0.0119	CcSEcCtD
Fluphenazine—Faecaloma—Doxorubicin—ovarian cancer	0.00219	0.0119	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Paclitaxel—ovarian cancer	0.00214	0.0116	CcSEcCtD
Fluphenazine—CALM2—myometrium—ovarian cancer	0.00203	0.0195	CbGeAlD
Fluphenazine—Pigmentation disorder—Epirubicin—ovarian cancer	0.00203	0.011	CcSEcCtD
Fluphenazine—CALM1—myometrium—ovarian cancer	0.00202	0.0194	CbGeAlD
Fluphenazine—Decreased appetite—Altretamine—ovarian cancer	0.00202	0.0109	CcSEcCtD
Fluphenazine—Hepatocellular injury—Melphalan—ovarian cancer	0.00202	0.0109	CcSEcCtD
Fluphenazine—CALM3—uterine cervix—ovarian cancer	0.00201	0.0193	CbGeAlD
Fluphenazine—CALM2—embryo—ovarian cancer	0.00195	0.0188	CbGeAlD
Fluphenazine—CALM1—embryo—ovarian cancer	0.00194	0.0187	CbGeAlD
Fluphenazine—CALM3—decidua—ovarian cancer	0.00191	0.0184	CbGeAlD
Fluphenazine—Pigmentation disorder—Doxorubicin—ovarian cancer	0.00188	0.0102	CcSEcCtD
Fluphenazine—CALM3—endometrium—ovarian cancer	0.00182	0.0175	CbGeAlD
Fluphenazine—Renal failure acute—Chlorambucil—ovarian cancer	0.00182	0.00983	CcSEcCtD
Fluphenazine—Menstruation irregular—Docetaxel—ovarian cancer	0.00181	0.00981	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Docetaxel—ovarian cancer	0.00181	0.00981	CcSEcCtD
Fluphenazine—CALM3—uterus—ovarian cancer	0.00168	0.0161	CbGeAlD
Fluphenazine—Dermatitis atopic—Paclitaxel—ovarian cancer	0.0016	0.00866	CcSEcCtD
Fluphenazine—CALM2—epithelium—ovarian cancer	0.00159	0.0153	CbGeAlD
Fluphenazine—CALM1—epithelium—ovarian cancer	0.00158	0.0152	CbGeAlD
Fluphenazine—Renal failure acute—Melphalan—ovarian cancer	0.00158	0.00857	CcSEcCtD
Fluphenazine—CALM2—uterine cervix—ovarian cancer	0.00158	0.0152	CbGeAlD
Fluphenazine—CALM1—uterine cervix—ovarian cancer	0.00157	0.0151	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Topotecan—ovarian cancer	0.00154	0.00835	CcSEcCtD
Fluphenazine—Lethargy—Topotecan—ovarian cancer	0.00152	0.00825	CcSEcCtD
Fluphenazine—CALM2—decidua—ovarian cancer	0.0015	0.0145	CbGeAlD
Fluphenazine—CALM1—decidua—ovarian cancer	0.0015	0.0144	CbGeAlD
Fluphenazine—HRH1—myometrium—ovarian cancer	0.00147	0.0142	CbGeAlD
Fluphenazine—Polyuria—Vinorelbine—ovarian cancer	0.00146	0.00787	CcSEcCtD
Fluphenazine—ADRA2A—myometrium—ovarian cancer	0.00145	0.0139	CbGeAlD
Fluphenazine—HTR2C—female reproductive system—ovarian cancer	0.00143	0.0138	CbGeAlD
Fluphenazine—CALM2—endometrium—ovarian cancer	0.00143	0.0137	CbGeAlD
Fluphenazine—CALM3—bone marrow—ovarian cancer	0.00142	0.0137	CbGeAlD
Fluphenazine—CALM1—endometrium—ovarian cancer	0.00142	0.0137	CbGeAlD
Fluphenazine—Cardiac arrest—Topotecan—ovarian cancer	0.00142	0.00769	CcSEcCtD
Fluphenazine—Blood disorder—Paclitaxel—ovarian cancer	0.00142	0.00767	CcSEcCtD
Fluphenazine—Cardiac arrest—Melphalan—ovarian cancer	0.00139	0.00753	CcSEcCtD
Fluphenazine—Nausea—Altretamine—ovarian cancer	0.00138	0.00746	CcSEcCtD
Fluphenazine—Pancytopenia—Chlorambucil—ovarian cancer	0.00138	0.00745	CcSEcCtD
Fluphenazine—CALM3—female gonad—ovarian cancer	0.00137	0.0132	CbGeAlD
Fluphenazine—CALM3—vagina—ovarian cancer	0.00136	0.0131	CbGeAlD
Fluphenazine—Tenderness—Paclitaxel—ovarian cancer	0.00136	0.00734	CcSEcCtD
Fluphenazine—Dermatitis atopic—Docetaxel—ovarian cancer	0.00136	0.00734	CcSEcCtD
Fluphenazine—CALM2—gonad—ovarian cancer	0.00132	0.0127	CbGeAlD
Fluphenazine—CALM1—gonad—ovarian cancer	0.00132	0.0127	CbGeAlD
Fluphenazine—CALM2—uterus—ovarian cancer	0.00132	0.0127	CbGeAlD
Fluphenazine—CALM1—uterus—ovarian cancer	0.00131	0.0126	CbGeAlD
Fluphenazine—Lethargy—Vinorelbine—ovarian cancer	0.0013	0.00706	CcSEcCtD
Fluphenazine—Pneumonia—Chlorambucil—ovarian cancer	0.0013	0.00704	CcSEcCtD
Fluphenazine—Body temperature increased—Carboplatin—ovarian cancer	0.00127	0.00686	CcSEcCtD
Fluphenazine—Dyskinesia—Paclitaxel—ovarian cancer	0.00126	0.00682	CcSEcCtD
Fluphenazine—Pancytopenia—Topotecan—ovarian cancer	0.00123	0.00663	CcSEcCtD
Fluphenazine—CALM3—testis—ovarian cancer	0.00122	0.0117	CbGeAlD
Fluphenazine—Pancytopenia—Melphalan—ovarian cancer	0.0012	0.0065	CcSEcCtD
Fluphenazine—HTR2A—embryo—ovarian cancer	0.00118	0.0114	CbGeAlD
Fluphenazine—CALM2—female reproductive system—ovarian cancer	0.00118	0.0114	CbGeAlD
Fluphenazine—CALM1—female reproductive system—ovarian cancer	0.00118	0.0113	CbGeAlD
Fluphenazine—Pneumonia—Topotecan—ovarian cancer	0.00116	0.00626	CcSEcCtD
Fluphenazine—HRH1—epithelium—ovarian cancer	0.00116	0.0111	CbGeAlD
Fluphenazine—HRH1—uterine cervix—ovarian cancer	0.00115	0.011	CbGeAlD
Fluphenazine—ADRA2A—uterine cervix—ovarian cancer	0.00113	0.0108	CbGeAlD
Fluphenazine—CALM2—bone marrow—ovarian cancer	0.00112	0.0107	CbGeAlD
Fluphenazine—CALM1—bone marrow—ovarian cancer	0.00111	0.0107	CbGeAlD
Fluphenazine—Dysphagia—Vinorelbine—ovarian cancer	0.0011	0.00598	CcSEcCtD
Fluphenazine—HRH1—decidua—ovarian cancer	0.00109	0.0105	CbGeAlD
Fluphenazine—CALM2—female gonad—ovarian cancer	0.00108	0.0104	CbGeAlD
Fluphenazine—ADRA2A—decidua—ovarian cancer	0.00107	0.0103	CbGeAlD
Fluphenazine—CALM1—female gonad—ovarian cancer	0.00107	0.0103	CbGeAlD
Fluphenazine—Urine output increased—Paclitaxel—ovarian cancer	0.00107	0.00579	CcSEcCtD
Fluphenazine—CALM2—vagina—ovarian cancer	0.00107	0.0103	CbGeAlD
Fluphenazine—CALM1—vagina—ovarian cancer	0.00106	0.0102	CbGeAlD
Fluphenazine—Pancytopenia—Vinorelbine—ovarian cancer	0.00105	0.00568	CcSEcCtD
Fluphenazine—HRH1—endometrium—ovarian cancer	0.00104	0.00997	CbGeAlD
Fluphenazine—ADRA2A—endometrium—ovarian cancer	0.00102	0.0098	CbGeAlD
Fluphenazine—Hepatocellular injury—Docetaxel—ovarian cancer	0.001	0.00543	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—ovarian cancer	0.000993	0.00537	CcSEcCtD
Fluphenazine—Pneumonia—Vinorelbine—ovarian cancer	0.00099	0.00536	CcSEcCtD
Fluphenazine—Polyuria—Paclitaxel—ovarian cancer	0.000979	0.0053	CcSEcCtD
Fluphenazine—HTR2A—epithelium—ovarian cancer	0.000965	0.00929	CbGeAlD
Fluphenazine—CALM2—testis—ovarian cancer	0.000954	0.00918	CbGeAlD
Fluphenazine—CALM1—testis—ovarian cancer	0.00095	0.00914	CbGeAlD
Fluphenazine—ADRA2A—gonad—ovarian cancer	0.000944	0.00909	CbGeAlD
Fluphenazine—Nasal congestion—Paclitaxel—ovarian cancer	0.000944	0.00511	CcSEcCtD
Fluphenazine—ADRA2A—uterus—ovarian cancer	0.000938	0.00903	CbGeAlD
Fluphenazine—Renal failure acute—Paclitaxel—ovarian cancer	0.000931	0.00504	CcSEcCtD
Fluphenazine—Agitation—Chlorambucil—ovarian cancer	0.000929	0.00502	CcSEcCtD
Fluphenazine—Angioedema—Chlorambucil—ovarian cancer	0.000923	0.005	CcSEcCtD
Fluphenazine—Agranulocytosis—Vinorelbine—ovarian cancer	0.000919	0.00497	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—ovarian cancer	0.000919	0.00497	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—ovarian cancer	0.000915	0.00495	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.000911	0.00493	CcSEcCtD
Fluphenazine—Leukopenia—Chlorambucil—ovarian cancer	0.000905	0.00489	CcSEcCtD
Fluphenazine—CALM3—lymph node—ovarian cancer	0.000881	0.00848	CbGeAlD
Fluphenazine—DRD2—testis—ovarian cancer	0.000877	0.00844	CbGeAlD
Fluphenazine—Lethargy—Paclitaxel—ovarian cancer	0.000877	0.00475	CcSEcCtD
Fluphenazine—Muscle spasms—Topotecan—ovarian cancer	0.000865	0.00468	CcSEcCtD
Fluphenazine—HRH1—female reproductive system—ovarian cancer	0.000859	0.00826	CbGeAlD
Fluphenazine—Dermatitis atopic—Doxorubicin—ovarian cancer	0.000846	0.00458	CcSEcCtD
Fluphenazine—ADRA2A—female reproductive system—ovarian cancer	0.000843	0.00812	CbGeAlD
Fluphenazine—CYP2E1—female reproductive system—ovarian cancer	0.000825	0.00794	CbGeAlD
Fluphenazine—Angioedema—Topotecan—ovarian cancer	0.000822	0.00445	CcSEcCtD
Fluphenazine—Cardiac arrest—Paclitaxel—ovarian cancer	0.000817	0.00442	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—ovarian cancer	0.00081	0.00439	CcSEcCtD
Fluphenazine—ABCB1—myometrium—ovarian cancer	0.000806	0.00776	CbGeAlD
Fluphenazine—Leukopenia—Topotecan—ovarian cancer	0.000805	0.00436	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—ovarian cancer	0.000804	0.00435	CcSEcCtD
Fluphenazine—HTR2A—gonad—ovarian cancer	0.000803	0.00773	CbGeAlD
Fluphenazine—Leukopenia—Melphalan—ovarian cancer	0.000788	0.00427	CcSEcCtD
Fluphenazine—HRH1—female gonad—ovarian cancer	0.000781	0.00752	CbGeAlD
Fluphenazine—HRH1—vagina—ovarian cancer	0.000776	0.00747	CbGeAlD
Fluphenazine—ABCB1—embryo—ovarian cancer	0.000775	0.00746	CbGeAlD
Fluphenazine—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00077	0.00417	CcSEcCtD
Fluphenazine—Erythema—Vinorelbine—ovarian cancer	0.00077	0.00416	CcSEcCtD
Fluphenazine—ADRA2A—female gonad—ovarian cancer	0.000767	0.00738	CbGeAlD
Fluphenazine—ADRA2A—vagina—ovarian cancer	0.000763	0.00734	CbGeAlD
Fluphenazine—Blood disorder—Doxorubicin—ovarian cancer	0.00075	0.00406	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—ovarian cancer	0.000744	0.00403	CcSEcCtD
Fluphenazine—Lethargy—Docetaxel—ovarian cancer	0.000743	0.00402	CcSEcCtD
Fluphenazine—Dysphagia—Paclitaxel—ovarian cancer	0.000743	0.00402	CcSEcCtD
Fluphenazine—Anaphylactic shock—Topotecan—ovarian cancer	0.000734	0.00397	CcSEcCtD
Fluphenazine—Dyskinesia—Epirubicin—ovarian cancer	0.00072	0.0039	CcSEcCtD
Fluphenazine—Anaphylactic shock—Melphalan—ovarian cancer	0.000719	0.00389	CcSEcCtD
Fluphenazine—HTR2A—female reproductive system—ovarian cancer	0.000717	0.0069	CbGeAlD
Fluphenazine—Decreased appetite—Chlorambucil—ovarian cancer	0.000717	0.00388	CcSEcCtD
Fluphenazine—Skin disorder—Topotecan—ovarian cancer	0.000713	0.00386	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000713	0.00386	CcSEcCtD
Fluphenazine—Pancytopenia—Paclitaxel—ovarian cancer	0.000705	0.00382	CcSEcCtD
Fluphenazine—Angioedema—Vinorelbine—ovarian cancer	0.000703	0.0038	CcSEcCtD
Fluphenazine—Tachycardia—Melphalan—ovarian cancer	0.000702	0.0038	CcSEcCtD
Fluphenazine—Skin disorder—Melphalan—ovarian cancer	0.000698	0.00378	CcSEcCtD
Fluphenazine—HRH1—testis—ovarian cancer	0.000693	0.00667	CbGeAlD
Fluphenazine—CALM2—lymph node—ovarian cancer	0.000692	0.00666	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.00069	0.00374	CcSEcCtD
Fluphenazine—Leukopenia—Vinorelbine—ovarian cancer	0.000689	0.00373	CcSEcCtD
Fluphenazine—CALM1—lymph node—ovarian cancer	0.000689	0.00663	CbGeAlD
Fluphenazine—ADRA2A—testis—ovarian cancer	0.000681	0.00655	CbGeAlD
Fluphenazine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.000678	0.00367	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—ovarian cancer	0.000677	0.00366	CcSEcCtD
Fluphenazine—Hypotension—Melphalan—ovarian cancer	0.000672	0.00363	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—ovarian cancer	0.000669	0.00362	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—ovarian cancer	0.000666	0.00361	CcSEcCtD
Fluphenazine—Pneumonia—Paclitaxel—ovarian cancer	0.000666	0.0036	CcSEcCtD
Fluphenazine—CYP2E1—testis—ovarian cancer	0.000666	0.00641	CbGeAlD
Fluphenazine—Hypertension—Vinorelbine—ovarian cancer	0.000664	0.00359	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—ovarian cancer	0.000657	0.00356	CcSEcCtD
Fluphenazine—Urticaria—Chlorambucil—ovarian cancer	0.000655	0.00355	CcSEcCtD
Fluphenazine—Dyspnoea—Topotecan—ovarian cancer	0.000655	0.00354	CcSEcCtD
Fluphenazine—CYP2D6—female reproductive system—ovarian cancer	0.000653	0.00629	CbGeAlD
Fluphenazine—Body temperature increased—Chlorambucil—ovarian cancer	0.000652	0.00353	CcSEcCtD
Fluphenazine—HTR2A—vagina—ovarian cancer	0.000649	0.00624	CbGeAlD
Fluphenazine—Dyspnoea—Melphalan—ovarian cancer	0.000641	0.00347	CcSEcCtD
Fluphenazine—Decreased appetite—Topotecan—ovarian cancer	0.000638	0.00345	CcSEcCtD
Fluphenazine—ABCB1—epithelium—ovarian cancer	0.000633	0.00609	CbGeAlD
Fluphenazine—Dysphagia—Docetaxel—ovarian cancer	0.00063	0.00341	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000628	0.0034	CcSEcCtD
Fluphenazine—Constipation—Topotecan—ovarian cancer	0.000628	0.0034	CcSEcCtD
Fluphenazine—ABCB1—uterine cervix—ovarian cancer	0.000627	0.00604	CbGeAlD
Fluphenazine—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000626	0.00339	CcSEcCtD
Fluphenazine—Decreased appetite—Melphalan—ovarian cancer	0.000625	0.00338	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—ovarian cancer	0.000619	0.00335	CcSEcCtD
Fluphenazine—Tachycardia—Vinorelbine—ovarian cancer	0.000613	0.00332	CcSEcCtD
Fluphenazine—Skin disorder—Vinorelbine—ovarian cancer	0.00061	0.0033	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000608	0.00329	CcSEcCtD
Fluphenazine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000608	0.00329	CcSEcCtD
Fluphenazine—Pancytopenia—Docetaxel—ovarian cancer	0.000598	0.00324	CcSEcCtD
Fluphenazine—ABCB1—decidua—ovarian cancer	0.000598	0.00575	CbGeAlD
Fluphenazine—CYP2D6—female gonad—ovarian cancer	0.000594	0.00572	CbGeAlD
Fluphenazine—Hypotension—Vinorelbine—ovarian cancer	0.000587	0.00318	CcSEcCtD
Fluphenazine—Oedema peripheral—Paclitaxel—ovarian cancer	0.000586	0.00317	CcSEcCtD
Fluphenazine—Pruritus—Chlorambucil—ovarian cancer	0.000583	0.00316	CcSEcCtD
Fluphenazine—Urticaria—Topotecan—ovarian cancer	0.000583	0.00316	CcSEcCtD
Fluphenazine—Body temperature increased—Topotecan—ovarian cancer	0.00058	0.00314	CcSEcCtD
Fluphenazine—HTR2A—testis—ovarian cancer	0.000579	0.00557	CbGeAlD
Fluphenazine—Urticaria—Melphalan—ovarian cancer	0.000571	0.00309	CcSEcCtD
Fluphenazine—ABCB1—endometrium—ovarian cancer	0.000567	0.00546	CbGeAlD
Fluphenazine—Pneumonia—Docetaxel—ovarian cancer	0.000565	0.00306	CcSEcCtD
Fluphenazine—Dyspnoea—Vinorelbine—ovarian cancer	0.00056	0.00303	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—ovarian cancer	0.00056	0.00303	CcSEcCtD
Fluphenazine—Eczema—Epirubicin—ovarian cancer	0.000547	0.00296	CcSEcCtD
Fluphenazine—Decreased appetite—Vinorelbine—ovarian cancer	0.000546	0.00295	CcSEcCtD
Fluphenazine—Hypersensitivity—Topotecan—ovarian cancer	0.000541	0.00293	CcSEcCtD
Fluphenazine—Constipation—Vinorelbine—ovarian cancer	0.000537	0.00291	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—ovarian cancer	0.000532	0.00288	CcSEcCtD
Fluphenazine—Hypersensitivity—Melphalan—ovarian cancer	0.00053	0.00287	CcSEcCtD
Fluphenazine—CYP2D6—testis—ovarian cancer	0.000527	0.00507	CbGeAlD
Fluphenazine—ABCB1—gonad—ovarian cancer	0.000526	0.00506	CbGeAlD
Fluphenazine—Agranulocytosis—Docetaxel—ovarian cancer	0.000524	0.00283	CcSEcCtD
Fluphenazine—ABCB1—uterus—ovarian cancer	0.000523	0.00503	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000521	0.00282	CcSEcCtD
Fluphenazine—Pruritus—Topotecan—ovarian cancer	0.000519	0.00281	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—ovarian cancer	0.000518	0.0028	CcSEcCtD
Fluphenazine—Erythema—Paclitaxel—ovarian cancer	0.000518	0.0028	CcSEcCtD
Fluphenazine—Pruritus—Melphalan—ovarian cancer	0.000509	0.00275	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000508	0.00275	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—ovarian cancer	0.000506	0.00274	CcSEcCtD
Fluphenazine—HRH1—lymph node—ovarian cancer	0.000502	0.00483	CbGeAlD
Fluphenazine—Lethargy—Epirubicin—ovarian cancer	0.000501	0.00271	CcSEcCtD
Fluphenazine—Urticaria—Vinorelbine—ovarian cancer	0.000499	0.0027	CcSEcCtD
Fluphenazine—Muscle spasms—Paclitaxel—ovarian cancer	0.000498	0.00269	CcSEcCtD
Fluphenazine—Body temperature increased—Vinorelbine—ovarian cancer	0.000496	0.00269	CcSEcCtD
Fluphenazine—Oedema peripheral—Docetaxel—ovarian cancer	0.000496	0.00269	CcSEcCtD
Fluphenazine—ADRA2A—lymph node—ovarian cancer	0.000493	0.00475	CbGeAlD
Fluphenazine—Renal failure acute—Doxorubicin—ovarian cancer	0.000492	0.00266	CcSEcCtD
Fluphenazine—Nausea—Chlorambucil—ovarian cancer	0.00049	0.00265	CcSEcCtD
Fluphenazine—Vision blurred—Paclitaxel—ovarian cancer	0.000488	0.00264	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000482	0.00261	CcSEcCtD
Fluphenazine—Agitation—Paclitaxel—ovarian cancer	0.000476	0.00257	CcSEcCtD
Fluphenazine—Angioedema—Paclitaxel—ovarian cancer	0.000473	0.00256	CcSEcCtD
Fluphenazine—ABCB1—female reproductive system—ovarian cancer	0.00047	0.00452	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00047	0.00254	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—ovarian cancer	0.000467	0.00253	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—ovarian cancer	0.000464	0.00251	CcSEcCtD
Fluphenazine—Leukopenia—Paclitaxel—ovarian cancer	0.000463	0.00251	CcSEcCtD
Fluphenazine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000463	0.0025	CcSEcCtD
Fluphenazine—Headache—Topotecan—ovarian cancer	0.00046	0.00249	CcSEcCtD
Fluphenazine—Hypertension—Paclitaxel—ovarian cancer	0.000447	0.00242	CcSEcCtD
Fluphenazine—Pruritus—Vinorelbine—ovarian cancer	0.000444	0.0024	CcSEcCtD
Fluphenazine—ABCB1—bone marrow—ovarian cancer	0.000444	0.00427	CbGeAlD
Fluphenazine—Erythema—Docetaxel—ovarian cancer	0.000439	0.00237	CcSEcCtD
Fluphenazine—Nausea—Topotecan—ovarian cancer	0.000436	0.00236	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000432	0.00234	CcSEcCtD
Fluphenazine—Dry mouth—Paclitaxel—ovarian cancer	0.000431	0.00233	CcSEcCtD
Fluphenazine—ABCB1—female gonad—ovarian cancer	0.000428	0.00411	CbGeAlD
Fluphenazine—Nausea—Melphalan—ovarian cancer	0.000427	0.00231	CcSEcCtD
Fluphenazine—ABCB1—vagina—ovarian cancer	0.000425	0.00409	CbGeAlD
Fluphenazine—Asthma—Epirubicin—ovarian cancer	0.000425	0.0023	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—ovarian cancer	0.000425	0.0023	CcSEcCtD
Fluphenazine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000422	0.00229	CcSEcCtD
Fluphenazine—Muscle spasms—Docetaxel—ovarian cancer	0.000422	0.00228	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—ovarian cancer	0.000421	0.00228	CcSEcCtD
Fluphenazine—Tachycardia—Paclitaxel—ovarian cancer	0.000412	0.00223	CcSEcCtD
Fluphenazine—Skin disorder—Paclitaxel—ovarian cancer	0.00041	0.00222	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—ovarian cancer	0.000403	0.00218	CcSEcCtD
Fluphenazine—Hypotension—Paclitaxel—ovarian cancer	0.000395	0.00214	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000395	0.00214	CcSEcCtD
Fluphenazine—Headache—Vinorelbine—ovarian cancer	0.000393	0.00213	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—ovarian cancer	0.000393	0.00213	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—ovarian cancer	0.000393	0.00213	CcSEcCtD
Fluphenazine—Leukopenia—Docetaxel—ovarian cancer	0.000393	0.00212	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—ovarian cancer	0.000389	0.00211	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000388	0.0021	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—ovarian cancer	0.000381	0.00206	CcSEcCtD
Fluphenazine—ABCB1—testis—ovarian cancer	0.000379	0.00365	CbGeAlD
Fluphenazine—Hypertension—Docetaxel—ovarian cancer	0.000379	0.00205	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—ovarian cancer	0.000379	0.00205	CcSEcCtD
Fluphenazine—Dyspnoea—Paclitaxel—ovarian cancer	0.000377	0.00204	CcSEcCtD
Fluphenazine—Somnolence—Paclitaxel—ovarian cancer	0.000376	0.00203	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—ovarian cancer	0.000373	0.00202	CcSEcCtD
Fluphenazine—Nausea—Vinorelbine—ovarian cancer	0.000373	0.00202	CcSEcCtD
Fluphenazine—Decreased appetite—Paclitaxel—ovarian cancer	0.000367	0.00199	CcSEcCtD
Fluphenazine—Dry mouth—Docetaxel—ovarian cancer	0.000365	0.00198	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000365	0.00198	CcSEcCtD
Fluphenazine—Constipation—Paclitaxel—ovarian cancer	0.000361	0.00195	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000359	0.00194	CcSEcCtD
Fluphenazine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000358	0.00194	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—ovarian cancer	0.000353	0.00191	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—ovarian cancer	0.000352	0.00191	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—ovarian cancer	0.00035	0.0019	CcSEcCtD
Fluphenazine—Tachycardia—Docetaxel—ovarian cancer	0.000349	0.00189	CcSEcCtD
Fluphenazine—Skin disorder—Docetaxel—ovarian cancer	0.000348	0.00188	CcSEcCtD
Fluphenazine—Urticaria—Paclitaxel—ovarian cancer	0.000336	0.00182	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—ovarian cancer	0.000335	0.00181	CcSEcCtD
Fluphenazine—Hypotension—Docetaxel—ovarian cancer	0.000335	0.00181	CcSEcCtD
Fluphenazine—Body temperature increased—Paclitaxel—ovarian cancer	0.000334	0.00181	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000327	0.00177	CcSEcCtD
Fluphenazine—Dyspnoea—Docetaxel—ovarian cancer	0.000319	0.00173	CcSEcCtD
Fluphenazine—Somnolence—Docetaxel—ovarian cancer	0.000318	0.00172	CcSEcCtD
Fluphenazine—Decreased appetite—Docetaxel—ovarian cancer	0.000311	0.00168	CcSEcCtD
Fluphenazine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000311	0.00168	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—ovarian cancer	0.00031	0.00168	CcSEcCtD
Fluphenazine—Constipation—Docetaxel—ovarian cancer	0.000306	0.00166	CcSEcCtD
Fluphenazine—Pruritus—Paclitaxel—ovarian cancer	0.000299	0.00162	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—ovarian cancer	0.000296	0.0016	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—ovarian cancer	0.000285	0.00154	CcSEcCtD
Fluphenazine—Body temperature increased—Docetaxel—ovarian cancer	0.000283	0.00153	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—ovarian cancer	0.000279	0.00151	CcSEcCtD
Fluphenazine—ABCB1—lymph node—ovarian cancer	0.000275	0.00265	CbGeAlD
Fluphenazine—Erythema—Doxorubicin—ovarian cancer	0.000274	0.00148	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—ovarian cancer	0.000272	0.00147	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—ovarian cancer	0.000265	0.00143	CcSEcCtD
Fluphenazine—Headache—Paclitaxel—ovarian cancer	0.000265	0.00143	CcSEcCtD
Fluphenazine—Hypersensitivity—Docetaxel—ovarian cancer	0.000264	0.00143	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—ovarian cancer	0.000263	0.00142	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—ovarian cancer	0.000258	0.0014	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—ovarian cancer	0.000255	0.00138	CcSEcCtD
Fluphenazine—Pruritus—Docetaxel—ovarian cancer	0.000253	0.00137	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—ovarian cancer	0.000252	0.00136	CcSEcCtD
Fluphenazine—Nausea—Paclitaxel—ovarian cancer	0.000251	0.00136	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—ovarian cancer	0.000246	0.00133	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—ovarian cancer	0.000245	0.00133	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000242	0.00131	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—ovarian cancer	0.000236	0.00128	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—ovarian cancer	0.000236	0.00128	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—ovarian cancer	0.000235	0.00127	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—ovarian cancer	0.000228	0.00123	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—ovarian cancer	0.000226	0.00122	CcSEcCtD
Fluphenazine—Headache—Docetaxel—ovarian cancer	0.000224	0.00121	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000223	0.00121	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—ovarian cancer	0.000218	0.00118	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—ovarian cancer	0.000217	0.00117	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—ovarian cancer	0.000215	0.00117	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—ovarian cancer	0.000215	0.00116	CcSEcCtD
Fluphenazine—Nausea—Docetaxel—ovarian cancer	0.000213	0.00115	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—ovarian cancer	0.00021	0.00114	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—ovarian cancer	0.000209	0.00113	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—ovarian cancer	0.000207	0.00112	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—ovarian cancer	0.000199	0.00108	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—ovarian cancer	0.000199	0.00107	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—ovarian cancer	0.000194	0.00105	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—ovarian cancer	0.000192	0.00104	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—ovarian cancer	0.000191	0.00103	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—ovarian cancer	0.000191	0.00103	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—ovarian cancer	0.000178	0.000963	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—ovarian cancer	0.000178	0.000961	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—ovarian cancer	0.000177	0.000956	CcSEcCtD
Fluphenazine—Flupentixol—ABCB1—ovarian cancer	0.000172	0.282	CrCbGaD
Fluphenazine—Pruritus—Epirubicin—ovarian cancer	0.000171	0.000925	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000165	0.000891	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—ovarian cancer	0.000158	0.000855	CcSEcCtD
Fluphenazine—Headache—Epirubicin—ovarian cancer	0.000151	0.000819	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—ovarian cancer	0.000143	0.000776	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—ovarian cancer	0.00014	0.000757	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—ovarian cancer	0.000133	0.000718	CcSEcCtD
Fluphenazine—Nefazodone—ABCB1—ovarian cancer	9.62e-05	0.158	CrCbGaD
Fluphenazine—Triflupromazine—ABCB1—ovarian cancer	9.38e-05	0.154	CrCbGaD
Fluphenazine—Trazodone—ABCB1—ovarian cancer	8.9e-05	0.146	CrCbGaD
Fluphenazine—Trifluoperazine—ABCB1—ovarian cancer	5.77e-05	0.0945	CrCbGaD
Fluphenazine—Quetiapine—ABCB1—ovarian cancer	5.59e-05	0.0917	CrCbGaD
Fluphenazine—Chlorpromazine—ABCB1—ovarian cancer	4.52e-05	0.0742	CrCbGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	8.54e-06	4.38e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PIK3CA—ovarian cancer	8.53e-06	4.38e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	8.51e-06	4.37e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	8.51e-06	4.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—ovarian cancer	8.49e-06	4.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—ovarian cancer	8.48e-06	4.35e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	8.47e-06	4.35e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MAPK3—ovarian cancer	8.43e-06	4.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MAPK3—ovarian cancer	8.43e-06	4.33e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	8.41e-06	4.32e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—ovarian cancer	8.41e-06	4.31e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	8.4e-06	4.31e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	8.38e-06	4.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ERBB2—ovarian cancer	8.38e-06	4.3e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	8.34e-06	4.28e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	8.32e-06	4.27e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MAPK1—ovarian cancer	8.3e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—ovarian cancer	8.29e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	8.28e-06	4.25e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—ovarian cancer	8.28e-06	4.25e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	8.27e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MTOR—ovarian cancer	8.27e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—ovarian cancer	8.27e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—ovarian cancer	8.27e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	8.26e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	8.26e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—ovarian cancer	8.24e-06	4.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—ovarian cancer	8.21e-06	4.21e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—ovarian cancer	8.21e-06	4.21e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—ovarian cancer	8.2e-06	4.21e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—ovarian cancer	8.2e-06	4.21e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.19e-06	4.2e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	8.17e-06	4.19e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	8.11e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB2—ovarian cancer	8.11e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB2—ovarian cancer	8.11e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	8.1e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	8.1e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—ovarian cancer	8.1e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	8.07e-06	4.14e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	8.06e-06	4.14e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	8.06e-06	4.13e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	8.04e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MAPK1—ovarian cancer	8.03e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MAPK1—ovarian cancer	8.03e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—ovarian cancer	8.02e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—ovarian cancer	8.02e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MTOR—ovarian cancer	8e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	8e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MTOR—ovarian cancer	8e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	8e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—ovarian cancer	7.95e-06	4.08e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—ovarian cancer	7.91e-06	4.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	7.9e-06	4.05e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—ovarian cancer	7.9e-06	4.05e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	7.88e-06	4.04e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—ovarian cancer	7.84e-06	4.02e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	7.83e-06	4.02e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—ovarian cancer	7.82e-06	4.01e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	7.81e-06	4.01e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—ovarian cancer	7.81e-06	4e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—ovarian cancer	7.8e-06	4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—ovarian cancer	7.8e-06	4e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	7.78e-06	3.99e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	7.76e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	7.76e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—ovarian cancer	7.76e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	7.7e-06	3.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—ovarian cancer	7.69e-06	3.94e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—ovarian cancer	7.69e-06	3.94e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—ovarian cancer	7.68e-06	3.94e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	7.68e-06	3.94e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—ovarian cancer	7.66e-06	3.93e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—ovarian cancer	7.65e-06	3.93e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	7.64e-06	3.92e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	7.64e-06	3.92e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	7.64e-06	3.92e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	7.61e-06	3.91e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—ovarian cancer	7.61e-06	3.9e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—ovarian cancer	7.59e-06	3.9e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—ovarian cancer	7.58e-06	3.89e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—ovarian cancer	7.58e-06	3.89e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—ovarian cancer	7.56e-06	3.88e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—ovarian cancer	7.56e-06	3.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—ovarian cancer	7.54e-06	3.87e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—ovarian cancer	7.54e-06	3.87e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	7.51e-06	3.85e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	7.51e-06	3.85e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CB—ovarian cancer	7.5e-06	3.85e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	7.48e-06	3.84e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—ovarian cancer	7.46e-06	3.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—ovarian cancer	7.4e-06	3.8e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—ovarian cancer	7.36e-06	3.78e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—ovarian cancer	7.36e-06	3.78e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	7.36e-06	3.77e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—ovarian cancer	7.35e-06	3.77e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—ovarian cancer	7.35e-06	3.77e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	7.34e-06	3.77e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	7.33e-06	3.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—ovarian cancer	7.31e-06	3.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—ovarian cancer	7.31e-06	3.75e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—ovarian cancer	7.27e-06	3.73e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—ovarian cancer	7.24e-06	3.71e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—ovarian cancer	7.21e-06	3.7e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—ovarian cancer	7.2e-06	3.69e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—ovarian cancer	7.19e-06	3.69e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—ovarian cancer	7.16e-06	3.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—ovarian cancer	7.16e-06	3.67e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—ovarian cancer	7.15e-06	3.67e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—ovarian cancer	7.15e-06	3.67e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—ovarian cancer	7.14e-06	3.66e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—ovarian cancer	7.14e-06	3.66e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	7.11e-06	3.65e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—ovarian cancer	7.11e-06	3.65e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	7.09e-06	3.64e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	7.09e-06	3.64e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	7.07e-06	3.63e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	7.06e-06	3.62e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	7.03e-06	3.61e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	7e-06	3.59e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	7e-06	3.59e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	7e-06	3.59e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	6.99e-06	3.59e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	6.99e-06	3.59e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	6.98e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—ovarian cancer	6.98e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—ovarian cancer	6.98e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—ovarian cancer	6.98e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	6.97e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—ovarian cancer	6.96e-06	3.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—ovarian cancer	6.96e-06	3.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—ovarian cancer	6.95e-06	3.57e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—ovarian cancer	6.95e-06	3.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—ovarian cancer	6.91e-06	3.55e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—ovarian cancer	6.91e-06	3.55e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—ovarian cancer	6.9e-06	3.54e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	6.86e-06	3.52e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—ovarian cancer	6.8e-06	3.49e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—ovarian cancer	6.77e-06	3.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	6.74e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	6.74e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—ovarian cancer	6.72e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	6.69e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—ovarian cancer	6.68e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—ovarian cancer	6.68e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—ovarian cancer	6.68e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—ovarian cancer	6.66e-06	3.42e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	6.61e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	6.61e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—ovarian cancer	6.6e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—ovarian cancer	6.59e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	6.51e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—ovarian cancer	6.5e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—ovarian cancer	6.48e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	6.47e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	6.45e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—ovarian cancer	6.44e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—ovarian cancer	6.44e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—ovarian cancer	6.39e-06	3.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—ovarian cancer	6.38e-06	3.27e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—ovarian cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—ovarian cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	6.24e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	6.24e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—ovarian cancer	6.22e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—ovarian cancer	6.19e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—ovarian cancer	6.18e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—ovarian cancer	6.18e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	6.17e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—ovarian cancer	6.17e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—ovarian cancer	6.17e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—ovarian cancer	6.17e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—ovarian cancer	6.17e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—ovarian cancer	6.16e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—ovarian cancer	6.16e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	6.11e-06	3.13e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—ovarian cancer	6.1e-06	3.13e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	6.07e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	6.07e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	6.06e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—ovarian cancer	6.03e-06	3.09e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	6.01e-06	3.09e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	5.98e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—ovarian cancer	5.97e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—ovarian cancer	5.94e-06	3.05e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	5.91e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	5.91e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—ovarian cancer	5.88e-06	3.02e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—ovarian cancer	5.88e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—ovarian cancer	5.86e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—ovarian cancer	5.83e-06	2.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—ovarian cancer	5.83e-06	2.99e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	5.81e-06	2.98e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—ovarian cancer	5.81e-06	2.98e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—ovarian cancer	5.74e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—ovarian cancer	5.74e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—ovarian cancer	5.74e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	5.71e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—ovarian cancer	5.71e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—ovarian cancer	5.69e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—ovarian cancer	5.69e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	5.62e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	5.62e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—ovarian cancer	5.62e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—ovarian cancer	5.62e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	5.62e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—ovarian cancer	5.61e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	5.53e-06	2.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—ovarian cancer	5.49e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—ovarian cancer	5.47e-06	2.8e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—ovarian cancer	5.4e-06	2.77e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—ovarian cancer	5.38e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—ovarian cancer	5.37e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	5.34e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—ovarian cancer	5.31e-06	2.72e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—ovarian cancer	5.31e-06	2.72e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—ovarian cancer	5.17e-06	2.65e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	5.11e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—ovarian cancer	5.04e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	5.04e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	4.96e-06	2.55e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—ovarian cancer	4.96e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—ovarian cancer	4.95e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—ovarian cancer	4.93e-06	2.53e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	4.89e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—ovarian cancer	4.88e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	4.88e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	4.88e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—ovarian cancer	4.76e-06	2.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—ovarian cancer	4.76e-06	2.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—ovarian cancer	4.72e-06	2.42e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—ovarian cancer	4.72e-06	2.42e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—ovarian cancer	4.66e-06	2.39e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—ovarian cancer	4.57e-06	2.34e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	4.51e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—ovarian cancer	4.51e-06	2.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—ovarian cancer	4.51e-06	2.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—ovarian cancer	4.46e-06	2.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—ovarian cancer	4.32e-06	2.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—ovarian cancer	4.32e-06	2.22e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	4.31e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—ovarian cancer	4.12e-06	2.11e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—ovarian cancer	3.98e-06	2.04e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—ovarian cancer	3.98e-06	2.04e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—ovarian cancer	3.73e-06	1.92e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.65e-06	1.87e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—ovarian cancer	3.52e-06	1.8e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—ovarian cancer	2.98e-06	1.53e-05	CbGpPWpGaD
